全文获取类型
收费全文 | 4676篇 |
免费 | 236篇 |
国内免费 | 252篇 |
出版年
2024年 | 19篇 |
2023年 | 74篇 |
2022年 | 124篇 |
2021年 | 140篇 |
2020年 | 131篇 |
2019年 | 154篇 |
2018年 | 162篇 |
2017年 | 112篇 |
2016年 | 133篇 |
2015年 | 277篇 |
2014年 | 343篇 |
2013年 | 417篇 |
2012年 | 216篇 |
2011年 | 214篇 |
2010年 | 160篇 |
2009年 | 224篇 |
2008年 | 217篇 |
2007年 | 230篇 |
2006年 | 186篇 |
2005年 | 200篇 |
2004年 | 197篇 |
2003年 | 150篇 |
2002年 | 129篇 |
2001年 | 86篇 |
2000年 | 84篇 |
1999年 | 89篇 |
1998年 | 78篇 |
1997年 | 75篇 |
1996年 | 62篇 |
1995年 | 65篇 |
1994年 | 57篇 |
1993年 | 48篇 |
1992年 | 36篇 |
1991年 | 38篇 |
1990年 | 44篇 |
1989年 | 38篇 |
1988年 | 24篇 |
1987年 | 31篇 |
1986年 | 18篇 |
1985年 | 11篇 |
1984年 | 21篇 |
1983年 | 11篇 |
1982年 | 13篇 |
1981年 | 5篇 |
1980年 | 7篇 |
1979年 | 4篇 |
1978年 | 3篇 |
1976年 | 2篇 |
1974年 | 2篇 |
1971年 | 1篇 |
排序方式: 共有5164条查询结果,搜索用时 171 毫秒
991.
992.
Darius J.R. Lane Dong-Hun Bae Aritee R. Siafakas Yohan Suryo Rahmanto Lina Al-Akra Patric J. Jansson Robert A. Casero Des R. Richardson 《生物化学与生物物理学报:疾病的分子基础》2018,1864(9):2793-2813
Many biological processes result from the coupling of metabolic pathways. Considering this, proliferation depends on adequate iron and polyamines, and although iron-depletion impairs proliferation, the metabolic link between iron and polyamine metabolism has never been thoroughly investigated. This is important to decipher, as many disease states demonstrate co-dysregulation of iron and polyamine metabolism. Herein, for the first time, we demonstrate that cellular iron levels robustly regulate 13 polyamine pathway proteins. Seven of these were regulated in a conserved manner by iron-depletion across different cell-types, with four proteins being down-regulated (i.e., acireductone dioxygenase 1 [ADI1], methionine adenosyltransferase 2α [MAT2α], Antizyme and polyamine oxidase [PAOX]) and three proteins being up-regulated (i.e., S-adenosyl methionine decarboxylase [AMD1], Antizyme inhibitor 1 [AZIN1] and spermidine/spermine-N1-acetyltransferase 1 [SAT1]). Depletion of iron also markedly decreased polyamine pools (i.e., spermidine and/or spermine, but not putrescine). Accordingly, iron-depletion also decreased S-adenosylmethionine that is essential for spermidine/spermine biosynthesis. Iron-depletion additionally reduced 3H-spermidine uptake in direct agreement with the lowered levels of the polyamine importer, SLC22A16. Regarding mechanism, the “reprogramming” of polyamine metabolism by iron-depletion is consistent with the down-regulation of ADI1 and MAT2α, and the up-regulation of SAT1. Moreover, changes in ADI1 (biosynthetic) and SAT1 (catabolic) partially depended on the iron-regulated changes in c-Myc and/or p53. The ability of iron chelators to inhibit proliferation was rescuable by putrescine and spermidine, and under some conditions by spermine. Collectively, iron and polyamine metabolism are intimately coupled, which has significant ramifications for understanding the integrated role of iron and polyamine metabolism in proliferation. 相似文献
993.
P. Olaizola P.Y. Lee-Law A. Arbelaiz A. Lapitz M.J. Perugorria L. Bujanda J.M. Banales 《生物化学与生物物理学报:疾病的分子基础》2018,1864(4):1293-1307
Cholangiopathies encompass a heterogeneous group of disorders affecting biliary epithelial cells (i.e. cholangiocytes). Early diagnosis, prognosis and treatment still remain clinically challenging for most of these diseases and are critical for adequate patient care. In the past decade, extensive research has emphasized microRNAs (miRs) as potential non-invasive biomarkers and tools to accurately identify, predict and treat cholangiopathies. MiRs can be released extracellularly conjugated with lipoproteins or encapsulated in extracellular vesicles (EVs). Research on EVs is also gaining attention since they are present in multiple biological fluids and may represent a relevant source of novel non-invasive biomarkers and be vehicles for new therapeutic approaches. This review highlights the most promising candidate miRs and EV-related biomarkers in cholangiopathies, as well as their relevant roles in biliary pathophysiology. This article is part of a Special Issue entitled: Cholangiocytes in Health and Disease edited by Jesus Banales, Marco Marzioni, Nicholas LaRusso and Peter Jansen.
Research strategy
PubMed search (April 2017) was done with the following terms: “microRNA”, “miRNA”, “miR”, “extracellular vesicles”, “EV”, “exosomes”, “primary biliary cholangitis”, “primary biliary cholangitis”, “PBC”, “primary sclerosing cholangitis”, “PSC”, “cholangiocarcinoma”, “CCA”, “biliary atresia”, “BA”, “polycystic liver diseases”, “PLD”, “cholangiopathies”, “cholestatic liver disease”. Most significant articles in full-text English were selected. The reference lists of selected papers were also considered. 相似文献994.
Marco Carbone Laura Cristoferi Paolo Angelo Cortesi Matteo Rota Antonio Ciaccio Stefano Okolicsanyi Marta Gemma Luciana Scalone Giancarlo Cesana Luca Fabris Michele Colledan Stefano Fagiuoli Gaetano Ideo Luca Saverio Belli Luca Maria Munari Lorenzo Mantovani Mario Strazzabosco 《生物化学与生物物理学报:疾病的分子基础》2018,1864(4):1415-1422
Background
Autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis represent the three major autoimmune liver diseases (AILDs). Their management is highly specialized, requires a multidisciplinary approach and often relies on expensive, orphan drugs. Unfortunately, their treatment is often unsatisfactory, and the care pathway heterogeneous across different centers. Disease-specific clinical outcome indicators (COIs) able to evaluate the whole cycle of care are needed to assist both clinicians and administrators in improving quality and value of care. Aim of our study was to generate a set of COIs for the three AILDs. We then prospectively validated these indicators based on a series of consecutive patients recruited at three tertiary clinical centers in Lombardy, Italy.Methods
In phase I using a Delphi method and a RAND 9-point appropriateness scale a set of COIs was generated. In phase II the indicators were applied in a real-life dataset.Results
Two-hundred fourteen patients were enrolled and followed-up for a median time of 54 months and the above COIs were recorded using a web-based electronic medical record program. The COIs were easy to collect in the clinical practice environment and their values compared well with the available natural history studies.Conclusions
We have generated a comprehensive set of COIs which sequentially capture different clinical outcome of the three AILDs explored. These indicators represent a critical tool to implement a value-based approach to patients with these conditions, to monitor, compare and improve quality through benchmarking of clinical performance and to assess the significance of novel drugs and technologies. This article is part of a Special Issue entitled: Cholangiocytes in Health and Diseaseedited by Jesus Banales, Marco Marzioni, Nicholas LaRusso and Peter Jansen. 相似文献995.
996.
Juan M. Suárez-Rivero Mario de la Mata Ana Delgado Pavón Marina Villanueva-Paz Suleva Povea-Cabello David Cotán Mónica Álvarez-Córdoba Irene Villalón-García Patricia Ybot-González Joaquín J. Salas Ovidio Muñiz Mario D. Cordero José A. Sánchez-Alcázar 《生物化学与生物物理学报:疾病的分子基础》2018,1864(12):3697-3713
Familial Hypercholesterolemia (FH) is an autosomal co-dominant genetic disorder characterized by elevated low-density lipoprotein (LDL) cholesterol levels and increased risk for premature cardiovascular disease. Here, we examined FH pathophysiology in skin fibroblasts derived from FH patients harboring heterozygous mutations in the LDL-receptor.Fibroblasts from FH patients showed a reduced LDL-uptake associated with increased intracellular cholesterol levels and coenzyme Q10 (CoQ10) deficiency, suggesting dysregulation of the mevalonate pathway.Secondary CoQ10 deficiency was associated with mitochondrial depolarization and mitophagy activation in FH fibroblasts. Persistent mitophagy altered autophagy flux and induced inflammasome activation accompanied by increased production of cytokines by mutant cells. All the pathological alterations in FH fibroblasts were also reproduced in a human endothelial cell line by LDL-receptor gene silencing.Both increased intracellular cholesterol and mitochondrial dysfunction in FH fibroblasts were partially restored by CoQ10 supplementation. Dysregulated mevalonate pathway in FH, including increased expression of cholesterogenic enzymes and decreased expression of CoQ10 biosynthetic enzymes, was also corrected by CoQ10 treatment.Reduced CoQ10 content and mitochondrial dysfunction may play an important role in the pathophysiology of early atherosclerosis in FH. The diagnosis of CoQ10 deficiency and mitochondrial impairment in FH patients may also be important to establish early treatment with CoQ10. 相似文献
997.
The RIG‐I‐like receptor LGP2 inhibits Dicer‐dependent processing of long double‐stranded RNA and blocks RNA interference in mammalian cells
下载免费PDF全文
![点击此处可从《The EMBO journal》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Annemarthe G van der Veen Pierre V Maillard Jan Marten Schmidt Sonia A Lee Safia Deddouche‐Grass Annabel Borg Svend Kjær Ambrosius P Snijders Caetano Reis e Sousa 《The EMBO journal》2018,37(4)
In vertebrates, the presence of viral RNA in the cytosol is sensed by members of the RIG‐I‐like receptor (RLR) family, which signal to induce production of type I interferons (IFN). These key antiviral cytokines act in a paracrine and autocrine manner to induce hundreds of interferon‐stimulated genes (ISGs), whose protein products restrict viral entry, replication and budding. ISGs include the RLRs themselves: RIG‐I, MDA5 and, the least‐studied family member, LGP2. In contrast, the IFN system is absent in plants and invertebrates, which defend themselves from viral intruders using RNA interference (RNAi). In RNAi, the endoribonuclease Dicer cleaves virus‐derived double‐stranded RNA (dsRNA) into small interfering RNAs (siRNAs) that target complementary viral RNA for cleavage. Interestingly, the RNAi machinery is conserved in mammals, and we have recently demonstrated that it is able to participate in mammalian antiviral defence in conditions in which the IFN system is suppressed. In contrast, when the IFN system is active, one or more ISGs act to mask or suppress antiviral RNAi. Here, we demonstrate that LGP2 constitutes one of the ISGs that can inhibit antiviral RNAi in mammals. We show that LGP2 associates with Dicer and inhibits cleavage of dsRNA into siRNAs both in vitro and in cells. Further, we show that in differentiated cells lacking components of the IFN response, ectopic expression of LGP2 interferes with RNAi‐dependent suppression of gene expression. Conversely, genetic loss of LGP2 uncovers dsRNA‐mediated RNAi albeit less strongly than complete loss of the IFN system. Thus, the inefficiency of RNAi as a mechanism of antiviral defence in mammalian somatic cells can be in part attributed to Dicer inhibition by LGP2 induced by type I IFNs. LGP2‐mediated antagonism of dsRNA‐mediated RNAi may help ensure that viral dsRNA substrates are preserved in order to serve as targets of antiviral ISG proteins. 相似文献
998.
999.
1000.
Structural basis for the flexible recognition of α‐glucan substrates by Bacteroides thetaiotaomicron SusG
下载免费PDF全文
![点击此处可从《Protein science : a publication of the Protein Society》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Gregory Arnal Darrell W. Cockburn Harry Brumer Nicole M. Koropatkin 《Protein science : a publication of the Protein Society》2018,27(6):1093-1101
Bacteria that reside in the mammalian intestinal tract efficiently hydrolyze dietary carbohydrates, including starch, that escape digestion in the small intestine. Starch is an abundant dietary carbohydrate comprised of α1,4 and α1,6 linked glucose, yet mammalian intestinal glucoamylases cannot effectively hydrolyze starch that has frequent α1,6 branching as these structures hinder recognition and processing by α1,4‐specific amylases. Here we present the structure of the cell surface amylase SusG from Bacteroides thetaiotaomicron complexed with a mixed linkage amylosaccharide generated from transglycosylation during crystallization. Although SusG is specific for α1,4 glucosidic bonds, binding of this new oligosaccharide at the active site demonstrates that SusG can accommodate α1,6 branch points at subsite ?3 to ?2, and also at subsite+1 adjacent to the site of hydrolysis, explaining how this enzyme may be able to process a wide range of limit dextrins in the intestinal environment. These data suggest that B. thetaiotaomicron and related organisms may have a selective advantage for amylosaccharide scavenging in the gut. 相似文献